(S)-2-((S)-2-(2-Benzamidoacetamido)-3-(1H-imidazol-4-yl)propanamido)-4-methylpentanoic acid

Catalog No. :
ACPSRA672
CAS No. :
31373-65-6
Molecular Formula :
C21H27N5O5
Molecular Weight :
429.48

IUPAC Name:benzoylglycyl-L-histidyl-L-leucine

(S)-2-((S)-2-(2-Benzamidoacetamido)-3-(1H-imidazol-4-yl)propanamido)-4-methylpentanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg98%$77.00Login to see priceInquiryInquiry
50mg98%$111.00Login to see priceIn stockInquiry
100mg98%$133.00Login to see priceIn stockInquiry
250mg98%$202.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-2-((S)-2-(2-Benzamidoacetamido)-3-(1H-imidazol-4-yl)propanamido)-4-methylpentanoic acid
IUPAC Namebenzoylglycyl-L-histidyl-L-leucine
Molecular FormulaC21H27N5O5
Molecular Weight429.48
SMILESCC(C)C[C@@H](C(O)=O)NC([C@H](CC1=CNC=N1)NC(CNC(C2=CC=CC=C2)=O)=O)=O
InChI KeyAAXWBCKQYLBQKY-IRXDYDNUSA-N
SynonymH-HIP-HIS-LEU-OH;Bz-Gly-His-Leu;N-Benzoyl-Gly-L-His-L-Leu-OH;Nα-(Benzoylglycyl)-L-His-L-Leu-OH;Hippuryl-L-histidyl-L-leucine, tetrahydrate,99%;BENZOYL-GLY-HIS-LEU;BZ-GLY-HIS-LEU-OH;HIPPURYL-L-HISTIDYL-L-LEUCINE
CAS No.31373-65-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACPSRA672 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPSRA672 route product structure diagram
    ACPSRA67231373-65-6 In Stock
Inquiry

2. ACPSRA672 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPSRA672 route product structure diagram
    ACPSRA67231373-65-6 In Stock
Inquiry

Comments (0)